findmyKOL
Clinical trialNCT06537557RecruitingInterventional

Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients

SponsorSecond Affiliated Hospital, Zhejiang University, School of MedicineEnrollment188Heat Stroke
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Heat stroke is a life-threatening clinical syndrome characterized by an imbalance between heat production and heat dissipation in the body, resulting from exposure to hot and humid environments and/or strenuous exercise. It is defined by an elevated core temperature exceeding 40°C and central nervous system abnormalities, accompanied by multi-organ dysfunction. The severity of cellular and tissue damage in heat stroke patients depends on the peak temperature reached and the duration of hyperthermia. Rapid reduction of core temperature can halt cellular damage, quickly reverse organ dysfunction, and improve patient outcomes. Therefore, early identification and rapid cooling are crucial to prevent irreversible damage and death in heat stroke patients. However, there is a lack of systematic and specific protocols to guide emergency medical staff in the standardized and effective management of body temperature in heat stroke patients. To address this, our research team previously developed an early in-hospital temperature management protocol for heat stroke patients based on the best available evidence, expert consultations, and expert panel meetings. This study aims to validate the feasibility and effectiveness of the protocol through clinical research, providing a basis for clinical practice.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Yongkang No.1 People'S Hospital

    Guli, Zhejiang, China

    Recruiting
  • Dongyang People'S Hospital

    Dongyang, China

    Recruiting
  • the Second Affiliated Hospital of Zhejiang University School of Medicine

    Hanzhou, China

    Recruiting
  • Jinhua Municipal Central Hospital

    Jinhua, China

    Recruiting
  • Jinhua People'S Hospital

    Jinhua, China

    Recruiting
  • Lanxi People'S Hospital

    Lanxi, China

    Recruiting
  • Yiwu Central Hospital

    Yiwu, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2024
Primary completion
30 Sept 2026
Completion
30 Dec 2026
Last update posted
27 May 2026
Registered enrollment
188
Registry id
NCT06537557

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.